Q
39.10
1.05 (2.76%)
| 前收盘价格 | 38.05 |
| 收盘价格 | 38.51 |
| 成交量 | 418,992 |
| 平均成交量 (3个月) | 687,271 |
| 市值 | 2,628,903,936 |
| 预期市盈率 (P/E Forward) | 16.29 |
| 价格/销量 (P/S) | 0.980 |
| 股市价格/股市净资产 (P/B) | 0.870 |
| 52周波幅 | |
| 利润日期 | 7 Nov 2024 |
| 营业毛利率 | -66.25% |
| 营业利益率 (TTM) | 7.12% |
| 稀释每股收益 (EPS TTM) | -27.81 |
| 季度收入增长率 (YOY) | -2.30% |
| 总债务/股东权益 (D/E MRQ) | 87.23% |
| 流动比率 (MRQ) | 1.38 |
| 营业现金流 (OCF TTM) | 99.70 M |
| 杠杆自由现金流 (LFCF TTM) | 158.72 M |
| 资产报酬率 (ROA TTM) | 1.04% |
| 股东权益报酬率 (ROE TTM) | -45.79% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 混合的 | 混合的 |
| Medical Devices (全球的) | 混合的 | 混合的 | |
| 股票 | QuidelOrtho Corporation | 看跌 | 看跌 |
AIStockmoo 评分
0.2
| 分析师共识 | 1.0 |
| 内部交易活动 | -3.0 |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 5.0 |
| 平均 | 0.20 |
|
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Small Value |
| 内部持股比例 | 1.46% |
| 机构持股比例 | 96.21% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 57.00 (Craig-Hallum, 45.78%) | 购买 |
| 中 | 53.50 (36.83%) | |
| 低 | 50.00 (UBS, 27.88%) | 保留 |
| 平均值 | 53.50 (36.83%) | |
| 总计 | 1 购买, 1 保留 | |
| 平均价格@调整类型 | 45.37 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| UBS | 19 Sep 2024 | 50.00 (27.88%) | 保留 | 46.23 |
| Craig-Hallum | 05 Sep 2024 | 57.00 (45.78%) | 购买 | 44.50 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CARLYLE GROUP INC. | - | 37.89 | -8,260,183 | -312,978,334 |
| 累积净数量 | -8,260,183 | |||
| 累积净值 ($) | -312,978,334 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 37.89 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| CARLYLE GROUP INC. | 21 Nov 2024 | 卖 (-) | 8,260,183 | 37.89 | 312,978,334 |
| 日期 | 类型 | 细节 |
|---|---|---|
| 19 Nov 2024 | 公告 | QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group |
| 19 Nov 2024 | 公告 | QuidelOrtho Corporation Announces Secondary Offering of Common Stock by the Carlyle Group |
| 07 Nov 2024 | 公告 | QuidelOrtho Reports Third Quarter 2024 Financial Results |
| 28 Oct 2024 | 公告 | QuidelOrtho to Participate in Three Upcoming Investor Conferences |
| 17 Oct 2024 | 公告 | QuidelOrtho to Report Third Quarter 2024 Financial Results |
| 09 Oct 2024 | 公告 | QuidelOrtho Announces New R&D Executive Leader |
| 10 Sep 2024 | 公告 | QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合